Tag: ImmunoTherapy

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Brooklyn ImmunoTherapeutics Receives License to Develop Cells to Treat Multiple Cancers & Disorders

David Kim04/30/2021

3061

Brooklyn ImmoTherapeutics LLC (NYSE: BTX) reported that is has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics Limited. ...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Fluidigm Corporation (NASDAQ: FLDM) Receives CE-IVD Mark for COVID-19 Test

financial buzz01/22/2021

1864

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Fluidigm Corporation Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19” Fluidigm Corporation (NASDAQ:...

Tag: ImmunoTherapy

Brooklyn ImmunoTherapeutics Receives License to Develop Cells to Treat Multiple Cancers & Disorders

“The Buzz” Show: Fluidigm Corporation (NASDAQ: FLDM) Receives CE-IVD Mark for COVID-19 Test

ABOUT US

Tweets